ImpactRx Buys TargetRx
ImpactRx, the medical marketplace data analytics firm, is buying TargetRx. Terms of the deal were not publicized. ImpactRx President and CEO, Gregory Ellis, will lead the combined company. ImpactRx is backed by Symphony Technology Group.
13 September 2011•3 mins read
